An Occupation-Based Healthy Nutrition and Wellness Program for Individuals With Schizophrenia

Doğu, Selma Ercan; Kokurcan, Ahmet; Örsel, Sibel

doi:10.1177/15394492231153113

Cited by 4 publications

(3 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, academic disadvantage and unemployment in schizophrenia are all part of a vicious cycle that frequently results in poor academic performance and joblessness. 21 , 30 , 31 …”

Section: Discussionmentioning

confidence: 99%

Determinants of Disability Among Individuals Living with Schizophrenia Attending Psychiatric Follow-Up Clinic in Jimma, Southwest Ethiopia: An Institution-Based Case-Control Study

Anbasse,

Tessema,

Negash

et al. 2024

NDT

View full text Add to dashboard Cite

Background Disability due to schizophrenia ends up with a higher degree of impairment in occupational, social and interpersonal functioning than other chronic illnesses. Despite severe and long-lasting schizophrenia associated disability, little has been explored so far to identify determinants of disability among individuals living with schizophrenia in Ethiopia. Objective To identify the determinants of disability among individuals living with schizophrenia attending the psychiatric follow-up clinic at Jimma Medical Center (JMC). Methods An institution-based unmatched case-control study was conducted among 98 Cases and 98 controls of individuals living with schizophrenia attending the JMC psychiatric clinic from September 1 to October 30, 2022. Consecutive sampling technique was used to recruit the required sample size of both groups. The cases group were participants who scored >12 total on the WHO Disability Assessment Scale version 2–0 (WHODAS 2–0) whereas the control group were those who scored 12 total on the WHODAS 2–0. Results Being jobless (AOR = 2.29; 95% CI: 1.10–4.77), longer than 5-year duration of illness without treatment (AOR = 3.13; 95% CI: 1.23–7.98), poor social support (AOR = 2.54; 95% CI: 1.04–6.22), negative symptoms (AOR = 2.45; 95% CI: 1.14–5.29), known family history of mental illness (AOR = 3.59; 95%: 1.67–7.73) and risky khat use (AOR = 4.37; 95% CI: 1.86–10.29) were found to be determinants of disability among schizophrenia patients. Conclusion Joblessness, longer than 5-year duration of illness without treatment, poor social support, negative symptoms, known family history of mental illness and risky khat use were found to be determinants of disability in schizophrenia patients. Interventions targeting reducing of disability and improving quality of life of schizophrenia patients should consider the aforementioned determinants.

show abstract

“…Furthermore, academic disadvantage and unemployment in schizophrenia are all part of a vicious cycle that frequently results in poor academic performance and joblessness. 21 , 30 , 31 …”

Section: Discussionmentioning

confidence: 99%

Determinants of Disability Among Individuals Living with Schizophrenia Attending Psychiatric Follow-Up Clinic in Jimma, Southwest Ethiopia: An Institution-Based Case-Control Study

Anbasse,

Tessema,

Negash

et al. 2024

NDT

View full text Add to dashboard Cite

show abstract

“…Considering that medications often show limited effectiveness in treating NS and cognitive deficits in SCZ, which substantially impact patients’ quality of life. 38 There are also no pharmacological therapies currently approved specifically for the treatment of negative symptoms, 39 and advances in conceptualisation and evaluation have not yet been fully reflected in treatment studies, 40 many of which have found that cognitive remediation can produce meaningful benefits in terms of cognition and function. 41 , 42 …”

Section: Discussionmentioning

confidence: 99%

Decline in Working Memory in Stable Schizophrenia May Be Related to Attentional Impairment: Mediating Effects of Negative Symptoms, a Cross-Sectional Study

Du,

Meng,

et al. 2024

NDT

View full text Add to dashboard Cite

Background Schizophrenia (SCZ) is a severe mental illness, Cognitive deficits and negative symptoms (NS) are prevalent in individuals with SCZ and are crucial indicators of functional recovery. It is well known that cognitive symptoms and negative symptoms are interrelated and that negative symptoms can affect the ability to take cognitive tests. However, the specific relationship between attention, working memory (WM), and NS in stable SCZ remains unclear. This study aims to explore these associations and provide valuable insights for the subsequent treatment of SCZ. Methods We conducted a comprehensive assessment of 145 patients with stable SCZ using the Chinese Brief Neurocognitive Suite of Tests (C-BCT) and the Positive and Negative Symptom Scale (PANSS). Results Patients with abnormal cognition exhibited significantly higher PANSS total scores, cognitive symptom scores, and NS than those with normal cognition (P<0.05). Pearson’s correlation analysis revealed significant positive correlations between digital breadth(DB) and continuous operation(CO) (r=0.389, P<0.001), as well as a significant negative correlation between DB and NS (r=−0.291, P<0.001). Moreover, CO showed a negative correlation with NS (r=−0.173, P<0.05). However, no significant correlations were found between the digital breadth-anterograde score and CO or NS (r=0.148, P>0.05; r=−0.068, P>0.05). Notably, NS were identified as a mediator in the relationship between attention and WM (effect size=0.024). Conclusion Our findings highlight significant associations between WM, attention, and NS in individuals with stable SCZ. Moreover, attention not only directly impacts WM but also indirectly influences it through NS. Addressing cognitive deficits and NS in the treatment of SCZ may lead to improved overall outcomes for affected individuals.

show abstract

“…Likewise, tests that measure functioning and quality of life more specifically, but also as a self-assessment by the patients themselves, could be useful in the continuation of treatment and its monitoring. 35 …”

Section: Discussionmentioning

confidence: 99%

Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study

Chiappini,

Di Carlo,

Mosca

et al. 2023

NDT

View full text Add to dashboard Cite

Introduction and Aim Psychotic and mood disorders are associated with significant functional impairment, premature mortality, physical morbidity, and great social and economic burden. The aim of this study is to evaluate the effectiveness of psychosocial, psychological, and rehabilitative interventions implemented in an Italian psychiatric inpatient facility, with a focus on patients with schizophrenia spectrum versus those with mood disorders. Methods A retrospective observational study was conducted in the psychiatric hospital Villa Maria Pia in Rome, Italy, during 2022. Patients with an established diagnosis of schizophrenia spectrum and mood disorder (ICD-9-CM) were assessed on admission (T0) and at the end of treatment (T1), using the Brief Psychiatric Rating Scale (BPRS) and the Global Assessment of Functioning (GAF). Interventions involved a multidisciplinary team and included individual and group activities. The t -test for independent samples was used to compare continuous variables between groups and Spearman correlation coefficient to calculate correlations between variables. Results The study sample consisted of 141 patients, the majority of them being adults (51.3 years ± 12.4) men (F/M= 68/73). Among them, 85 patients (60.3%) actively engaged in psychosocial and rehabilitative interventions and, compared to non-participating individuals, they showed lower functioning and symptoms at discharge (delta GAF was significantly higher among patients who had taken part in the psychosocial activities, t = −2.095; p = 0.038). Considering the index computed (n of interventions/days of hospitalization), the number of psychosocial activities was positively correlated with the improvement in patients’ functioning in the sample taking part in activities (r = 0.272, p = 0.012), especially with psychotherapy and support groups (r = 0.202, p = 0.017 and r = 0.188, p = 0.025, respectively). Splitting the total sample into schizophrenia-spectrum disorder (N = 37) and mood disorder (N = 48) groups, the positive correlations between GAF improvement and participation in psychosocial activities were confirmed only in the schizophrenia-spectrum group. These correlations were not significant for symptomatology (BPRS) either in the total or the individual group. Conclusion Evidence from our study suggests that inpatient rehabilitation can be effective and useful for people with severe mental disorders. Further investigations are needed to better understand its effectiveness on improving quality of life and social functioning in the long term.

show abstract

An Occupation-Based Healthy Nutrition and Wellness Program for Individuals With Schizophrenia

Cited by 4 publications

References 34 publications

Determinants of Disability Among Individuals Living with Schizophrenia Attending Psychiatric Follow-Up Clinic in Jimma, Southwest Ethiopia: An Institution-Based Case-Control Study

Determinants of Disability Among Individuals Living with Schizophrenia Attending Psychiatric Follow-Up Clinic in Jimma, Southwest Ethiopia: An Institution-Based Case-Control Study

Decline in Working Memory in Stable Schizophrenia May Be Related to Attentional Impairment: Mediating Effects of Negative Symptoms, a Cross-Sectional Study

Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study

Contact Info

Product

Resources

About